Bibliometric Insights Into the Dynamics of Schizophrenia and Obesity Research
Main Article Content
Abstract
Schizophrenia and obesity are two complicated health disorders that affect both individuals and society. Comprehensive research that investigates the interplay between these two conditions is required. Therefore, a bibliometric analysis was performed to investigate the landscape of schizophrenia and obesity research. The bibliometric analysis was conducted using the Scopus analyser and VOSviewer software. There have been fluctuations in annual output. De Hert is the most influential contributor in this research field, where medicine dominates as the primary subject area (57.5%). A study on the prevalence of metabolic syndrome among schizophrenia is the most cited article. The studies were carried out by distinct clusters of experts, with the United States being the leading contributor. An analysis of the author's keywords showed five main areas of interest. This bibliometric analysis offers an in-depth review of the knowledge gap in these fields and suggests specific recommendations for future research.
Downloads
Article Details
References
de Winter L, Vermeulen JM, Couwenbergh C, van Weeghel J, Hasson-Ohayon I, Mulder CL, et al. Short- and long-term changes in symptom dimensions among patients with schizophrenia spectrum disorders and different durations of illness: A meta-analysis. Vol. 164, J Psychiatry Res. 2023. p. 416–39. doi:10.1016/j.jpsychires.2023.06.031.
Guria S, Hoory A, Das S, Chattopadhyay D, Mukherjee S. Adipose tissue macrophages and their role in obesity-associated insulin resistance: an overview of the complex dynamics at play. Vol. 43, Biosci Rep. 2023. doi:10.1042/BSR20220200.
Gong JW, Luo D, Liu WJ, Zhang J, Chen ZR, Wang QY, et al. Challenges faced when living with schizophrenia in the community: A narrative inquiry. Int J Soc Psychiatry. 2023;69(2):420–9. doi:10.1177/00207640221109168.
James WPT. Obesity: A global public health challenge. Clin Chem. 2018;64(1). doi:10.1373/clinchem.2017.273052.
Li X, Shi X, Tan Y, Yu Y, Tang C, Xu G, et al. Metabolic indexes of obesity in patients with common mental disorders in stable stage. BMC Psychiatry. 2022;22(1). doi:10.1186/s12888-022-03752-2.
Manu P, Dima L, Shulman M, Vancampfort D, De Hert M, Correll CU. Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management. Acta Psychiatr Scand. 2015;132(2):97–108. doi:10.1111/acps.12445.
Li I, Hester J. The Association between Schizophrenia Clinical Severity and Obesity Risk: A Literature Review. J Stud Res. 2021;10(4). doi:10.47611/jsrhs.v10i4.2063.
Singh R, Stogios N, Smith E, Lee J, Maksyutynsk K, Au E, et al. Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review. Vol. 12, Ther Adv Psychopharmacol. 2022. doi:10.1177/20451253221096525.
Roosterman D, Cottrell GS. The two-cell model of glucose metabolism: a hypothesis of schizophrenia. Vol. 26, Mol Psychiatry. 2021. doi:10.1038/s41380-020-00980-4.
Casanova D, Kushner RF, Ciemins EL, Smolarz BG, Chambers E, Leaver-Schmidt E, et al. Building Successful Models in Primary Care to Improve the Management of Adult Patients with Obesity. Popul Health Manag. 2021;24(5). doi:10.1089/pop.2020.0340.
Zhang Y, Xu Y, Li S. Bibliometrics Analysis of Diagnostic Test Accuracy Studies of Bladder Cancer. Dis Markers. 2021;2021. doi:10.1155/2021/8870353.
Nevzorova EN, Bobek S, Kireenko AP, Sklyarov RA. Tax evasion: the discourse among government, business and science community based on bibliometric analysis. J Tax Reform. 2016;2(3). doi:10.15826/jtr.2016.2.3.026.
Herrera-Franco G, Carrión-Mero P, Montalván-Burbano N, Caicedo-Potosí J, Berrezueta E. Geoheritage and Geosites: A Bibliometric Analysis and Literature Review. Geosci. 2022;12(4). doi:10.3390/geosciences12040169.
Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM. How to conduct a bibliometric analysis: An overview and guidelines. J Bus Res. 2021;133. doi:10.1016/j.jbusres.2021.04.070.
Chàfer M, Cabeza LF, Pisello AL, Tan CL, Wong NH. Trends and gaps in global research of greenery systems through a bibliometric analysis. Sustain Cities Soc. 2021;65. doi:10.1016/j.scs.2020.102608.
Al-Khoury A, Hussein SA, Abdulwhab M, Aljuboori ZM, Haddad H, Ali MA, et al. Intellectual Capital History and Trends: A Bibliometric Analysis Using Scopus Database. Sustain. 2022;14(18). doi:10.3390/su141811615.
Gu D, Li T, Wang X, Yang X, Yu Z. Visualizing the intellectual structure and evolution of electronic health and telemedicine research. Int J Med Inform. 2019;130. doi:10.1016/j.ijmedinf.2019.08.007.
van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2). doi:10.1007/s11192-009-0146-3.
Appio FP, Cesaroni F, Di Minin A. Visualizing the structure and bridges of the intellectual property management and strategy literature: a document co-citation analysis. Scientometrics. 2014;101(1). doi:10.1007/s11192-014-1329-0.
Li H, An H, Wang Y, Huang J, Gao X. Evolutionary features of academic articles co-keyword network and keywords co-occurrence network: Based on two-mode affiliation network. Physica A. 2016;450. doi:10.1016/j.physa.2016.01.017.
Allahverdiyev M, Yucesoy Y. Development stages and types of glass art from past to present. Ponte. 2017;73(4). doi:10.21506/j.ponte.2017.4.53.
Appio FP, Martini A, Massa S, Testa S. Unveiling the intellectual origins of Social Media-based innovation: insights from a bibliometric approach. Scientometrics. 2016;108(1). doi:10.1007/s11192-016-1955-9.
Fahimnia B, Sarkis J, Davarzani H. Green supply chain management: A review and bibliometric analysis. Vol. 162, Int J Prod Econ. 2015. doi:10.1016/j.ijpe.2015.01.003.
Liu Z, Yin Y, Liu W, Dunford M. Visualizing the intellectual structure and evolution of innovation systems research: a bibliometric analysis. Scientometrics. 2015;103(1). doi:10.1007/s11192-014-1517-y.
McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res. 2005;80(1). doi:10.1016/j.schres.2005.07.014.
Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Vol. 150, Am Heart J. 2005. doi:10.1016/j.ahj.2005.02.007.
Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: A systematic review and meta-analysis. Vol. 14, World Psychiatry. 2015. doi:10.1002/wps.20252.
Mitchell AJ, Vancampfort D, Sweers K, Van Winkel R, Yu W, De Hert M. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis. Vol. 39, Schizophr Bull. 2013. doi:10.1093/schbul/sbr148.
Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, et al. Physical health monitoring of patients with schizophrenia. Vol. 161, Am J Psychiatry. 2004. doi:10.1176/appi.ajp.161.8.1334.
Ross CA, Margolis RL, Reading SAJ, Pletnikov M, Coyle JT. Neurobiology of Schizophrenia. Vol. 52, Neuron. 2006. doi:10.1016/j.neuron.2006.09.015.
Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Vol. 10, Annu Rev Clin Psychol. 2014. doi:10.1146/annurev-clinpsy-032813-153657.
Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Vol. 50, Aust N Z J Psychiatry. 2016. doi:10.1177/0004867416641195.
Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015;14(2). doi:10.1002/wps.20204.
De Hert M, Schreurs V, Vancampfort D, Van Winkel R. Metabolic syndrome in people with schizophrenia: A review. Vol. 8, World Psychiatry. Masson SpA; 2009. p. 15–22. doi:10.1002/j.2051-5545.2009.tb00199.x.
Goh KK, Chen CYA, Wu TH, Chen CH, Lu ML. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction. Vol. 23, Int J Mol Sci. 2022. doi:10.3390/ijms23137092.
MacKenzie NE, Kowalchuk C, Agarwal SM, Costa-Dookhan KA, Caravaggio F, Gerretsen P, et al. Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia. Vol. 9, Front Psychiatry. 2018. doi:10.3389/fpsyt.2018.00622.
Lee K, Abraham S, Cleaver R. A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis. Vol. 78, Gen Hosp Psychiatry. 2022. doi:10.1016/j.genhosppsych.2022.07.006.
Lu C, Jin D, Palmer N, Fox K, Kohane IS, Smoller JW, et al. Large-scale real-world data analysis identifies comorbidity patterns in schizophrenia. Transl Psychiatry. 2022;12(1). doi:10.1038/s41398-022-01916-y.
Padmavati R, Kantipudi SJ, Balasubramanian S, Raghavan V. Cardiovascular Diseases and Schizophrenia in India: Evidence, Gaps, and Way Forward. Vol. 12, Front Psychiatry. 2021. doi:10.3389/fpsyt.2021.639295.
Agarwal SM, Stogios N, Ahsan ZA, Lockwood JT, Duncan MJ, Takeuchi H, et al. Pharmacological interventions for prevention of weight gain in people with schizophrenia. Vol. 2022, Cochrane Database Syst Rev. 2022. doi:10.1002/14651858.CD013337.pub2.
Hahn M, Remington G, Duncan MJ, Cohn T, Faulkner GEJ. Pharmacological interventions for reducing weight gain in schizophrenia. Cochrane Database Syst Rev. 2014;2014(6). doi:10.1002/14651858.CD011127.
Faulkner G, Duncan MJ, Hahn M, Remington G, Cohn T. Behavioural interventions for reducing weight gain in schizophrenia. Cochrane Database Syst Rev. 2013;2013(10). doi:10.1002/14651858.CD010781.
Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev. 2007. doi:10.1002/14651858.CD005148.pub2.
Maillard AM, Ruef A, Pizzagalli F, Migliavacca E, Hippolyte L, Adaszewski S, et al. The 16p11.2 locus modulates brain structures common to autism, schizophrenia and obesity. Mol Psychiatry. 2015;20(1). doi:10.1038/mp.2014.145.
Henderson DC, Vincenzi B, Andrea N V., Ulloa M, Copeland PM. Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. Vol. 2, The Lancet Psychiatry. 2015. doi:10.1016/S2215-0366(15)00115-7.
Zhang ZJ, Yao ZJ, Liu W, Fang Q, Reynolds GP. Effects of antipsychotics on fat deposition and changes in leptin and insulin levels: Magnetic resonance imaging study of previously untreated people with schizophrenia. Br J Psychiatry. 2004;184(JAN.). doi:10.1192/bjp.184.1.58.
Brar JS, Ganguli R, Pandina G, Turkoz I, Berry S, Mahmoud R. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2005;66(2). doi:10.4088/JCP.v66n0208.
Allison DB, Mackell JA, McDonnell DD. The impact of weight gain on quality of life among persons with schizophrenia. Psychiatric Services. 2003;54(4). doi:10.1176/appi.ps.54.4.565.